Elevation of Intracellular cAMP Inhibits Growth Factor-Mediated Matrix Metalloproteinase-9 Induction and Keratinocyte Migration

Abstract

Receptor tyrosine kinases are regulators of diverse cellular functions including cell growth, cell survival, differentiation, locomotion, and morphogenesis. Activation of the cAMP-dependent protein kinase A inhibits receptor tyrosine kinase-stimulated growth responses in a number of cell types. In this study, we investigated the consequences of elevated cAMP on growth factor-mediated keratinocyte migration and matrix metalloproteinase (MMP)-9 induction in a human keratinocyte cell line. We found that elevation of intracellular cAMP by forskolin abolishes epidermal growth factor (EGF)- or scatter factor/hepatocyte growth factor-dependent colony dispersion. Concentrations of forskolin that inhibit growth factor-induced motility also eliminate EGF- or scatter factor/hepatocyte growth factor-dependent induction of the 92-kDa gelatinase/MMP-9. In contrast to findings obtained in fibroblasts, elevated intracellular cAMP did not interfere with growth factor-dependent activation of the p42/44 extracellular signal-regulated kinases, indicating that cAMP-dependent inhibition of migration and MMP-9 induction does not occur through perturbation of the extracellular signal-regulated kinases/mitogen-activated protein kinase pathway. However, forskolin effectively inhibited EGF-dependent activation of c-Jun N-terminal kinase and p38, demonstrating that cAMP selectively interferes with a different subset of growth factor-induced mitogen-activated protein kinase signaling cascades than reported previously in fibroblasts. These findings illustrate that EGF concurrently activates multiple mitogen-activated protein kinase signaling cascades in keratinocytes and suggests that each pathway contributes to maximal EGF-dependent migration and proteinase induction.

Footnotes

  • Laurie G. Hudson, Ph.D., Program in Pharmacology and Toxicology, University of New Mexico Health Sciences Center, 2502 Marble N.E., Albuquerque, NM 87131. E-mail:lghudson{at}unm.edu

  • This work was supported by National Institutes of Health Grant RO1AR42989 (L.G.H.) and in part by NIH Grants CA72498 (E.V.W.) and RO1DE12458 (L.G.H.). L.J.M. was supported by NIH Training Grant T32GM08061.

  • Abbreviations:
    EGF
    epidermal growth factor
    MMP
    matrix metalloproteinase
    PKA
    cAMP-dependent protein kinase
    ERK
    extracellular signal-regulated kinase
    MAPK
    mitogen-activated protein kinase
    SF/HGF
    scatter factor/hepatocyte growth factor
    JNK
    c-Jun N-terminal kinase
    GST
    glutathione S-transferase
    NGF
    nerve growth factor
    HOG
    high-osmolarity glycerol
    SCC
    squamous cell carcinoma
    • Received December 13, 1999.
    • Accepted March 28, 2000.
« Previous | Next Article »Table of Contents